First United Bank & Trust’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.32K Hold
20
﹤0.01% 380
2026
Q1
$3.67K Hold
20
﹤0.01% 363
2025
Q4
$3.52K Hold
20
﹤0.01% 360
2025
Q3
$2.8K Hold
20
﹤0.01% 395
2025
Q2
$2.51K Hold
20
﹤0.01% 363
2025
Q1
$2.74K Hold
20
﹤0.01% 372
2024
Q4
$3.06K Hold
20
﹤0.01% 358
2024
Q3
$3.88K Hold
20
﹤0.01% 354
2024
Q2
$4.64K Hold
20
﹤0.01% 366
2024
Q1
$4.31K Hold
20
﹤0.01% 381
2023
Q4
$5.17K Buy
+20
New +$4.91K ﹤0.01% 386

Other funds holding BIIB

First United Bank & Trust's BIIB Position: Q2 2026 in Review

First United Bank & Trust held its Biogen (BIIB) position steady in Q2 2026 at 20 shares worth $4.32K. The position accounts for ﹤0.01% of the portfolio, ranked #380.

First United Bank & Trust first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.17K in Q4 2023. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • First United Bank & Trust held 20 shares of Biogen worth $4.32K as of Q2 2026.
  • First United Bank & Trust left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of First United Bank & Trust's portfolio in Q2 2026, its #380 holding.
  • First United Bank & Trust first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
  • First United Bank & Trust's Biogen position peaked at $5.17K in Q4 2023.
  • 269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on First United Bank & Trust's 13F filing for Q2 2026, filed 20 Jul 2026.